Available data suggests that hyperglycemia may cause the downregulation of GIP-R, thus reducing its response (42)
While GLP-1 agonists were already on the map before, as they became popular for their effectiveness in treating type 2 diabetes and significantly promoting weight loss in obesity, their inclusion in the WHO essential medicines list clears the path towards equitable access
5-12 The most common patient-reported adverse effects (AEs) associated with GLP-1 RAs and dual GIP/GLP-1 RAs are gastrointestinal (GI) in nature and may include abdominal pain, constipation, diarrhea, nausea, and vomiting
While both lipo shots and GLP-1 weight loss injections can support weight management, they work through entirely different mechanisms: Many of our patients use both treatments together
Foods that trigger heartburn on tirzepatide Some foods relax the lower esophageal sphincter, increase acid production, or slow gastric emptying further